Medikamentöse Senkung des LDL-Cholesterins

Praxis (Bern 1994). 2017 Aug;106(17):933-940. doi: 10.1024/1661-8157/a002759.
[Article in German]
No abstract available

Keywords: Cholesterin; Cholesterol; Cholestérol; Ezetimib; PCSK9 inhibitors; PCSK9-Hemmer; Statin; cardiovascular risk; ezetimibe; inhibiteur de la PCSK9; kardiovaskuläres Risiko; statin; statine; ézétimibe.

Publication types

  • Review

MeSH terms

  • Cholesterol, LDL / blood*
  • Ezetimibe / therapeutic use
  • Fibric Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / drug therapy*
  • PCSK9 Inhibitors
  • Secondary Prevention

Substances

  • Cholesterol, LDL
  • Fibric Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • PCSK9 Inhibitors
  • PCSK9 protein, human
  • Ezetimibe